F&O Advisor P/S (CVR 44612658)
|
NORMAL
|
02.02.2024
|
100,00%
|
100,00%
|
Orbis Medicines ApS (CVR 42715646)
|
NORMAL
|
02.02.2024
|
50,00-66,66%
|
50,00-66,66%
|
Commit Biologics ApS (CVR 42642649)
|
NORMAL
|
19.01.2024
|
25,00-33,32%
|
25,00-33,32%
|
Hoba Therapeutics ApS (CVR 38231170)
|
NORMAL
|
08.12.2023
|
33,33-49,99%
|
33,33-49,99%
|
Muna Therapeutics ApS (CVR 41142871)
|
NORMAL
|
27.11.2023
|
15,00-19,99%
|
15,00-19,99%
|
Selskabet af 21. november 2023 ApS (CVR 44445832)
|
NORMAL
|
22.11.2023
|
20,00-24,99%
|
20,00-24,99%
|
Glentra Fund I K/S (CVR 43718037)
|
NORMAL
|
13.09.2023
|
50,00-66,66%
|
50,00-66,66%
|
STIPE Therapeutics ApS (CVR 39691175)
|
NORMAL
|
12.09.2023
|
25,00-33,32%
|
25,00-33,32%
|
Antraka ApS (CVR 44229447)
|
NORMAL
|
11.08.2023
|
100,00%
|
100,00%
|
Breye Therapeutics ApS (CVR 40279865)
|
NORMAL
|
06.06.2023
|
33,33-49,99%
|
33,33-49,99%
|
Reapplix A/S (CVR 31261570)
|
NORMAL
|
23.05.2023
|
15,00-19,99%
|
15,00-19,99%
|
ADCendo ApS (CVR 38780093)
|
NORMAL
|
16.03.2023
|
15,00-19,99%
|
15,00-19,99%
|
Hemab ApS (CVR 40837590)
|
NORMAL
|
15.02.2023
|
20,00-24,99%
|
20,00-24,99%
|
Draupnir Bio ApS (CVR 38546880)
|
NORMAL
|
10.02.2023
|
25,00-33,32%
|
25,00-33,32%
|
Glentra GP ApS (CVR 43705369)
|
NORMAL
|
30.12.2022
|
20,00-24,99%
|
20,00-24,99%
|
AVILEX PHARMA ApS (CVR 34896828)
|
NORMAL
|
23.09.2022
|
50,00-66,66%
|
50,00-66,66%
|
Indkøbsselskabet Novo Holdings A/S (CVR 43345591)
|
NORMAL
|
01.07.2022
|
100,00%
|
100,00%
|
BIOSYNTIA ApS (CVR 34892970)
|
NORMAL
|
20.06.2022
|
33,33-49,99%
|
33,33-49,99%
|
DADES A/S (CVR 10432928)
|
NORMAL
|
29.04.2022
|
50,00-66,66%
|
50,00-66,66%
|
Novo Holdings Invest Asia A/S (CVR 42961795)
|
NORMAL
|
10.01.2022
|
100,00%
|
100,00%
|
Ritedose HoldCo A/S (CVR 42851051)
|
NORMAL
|
22.11.2021
|
100,00%
|
100,00%
|
byFounders VC Fund II K/S (CVR 41832290)
|
NORMAL
|
09.07.2021
|
15,00-19,99%
|
15,00-19,99%
|
Baneby Konsortiet K/S (CVR 42531871)
|
NORMAL
|
08.07.2021
|
33,33-49,99%
|
33,33-49,99%
|
Renewable Energy Partnership I CIV K/S (CVR 42132721)
|
NORMAL
|
31.03.2021
|
33,33-49,99%
|
33,33-49,99%
|
Renewable Energy Partnership I GP ApS (CVR 42118176)
|
NORMAL
|
03.02.2021
|
33,33-49,99%
|
33,33-49,99%
|
Renewable Energy Partnership P/S (CVR 42126144)
|
NORMAL
|
03.02.2021
|
33,33-49,99%
|
33,33-49,99%
|
MINERVAX ApS (CVR 32673287)
|
NORMAL
|
10.12.2020
|
15,00-19,99%
|
15,00-19,99%
|
Novo Capital Investors P/S (CVR 41882395)
|
NORMAL
|
25.11.2020
|
100,00%
|
100,00%
|
iSD Immunotech ApS (CVR 30738276)
|
NORMAL
|
16.11.2020
|
15,00-19,99%
|
15,00-19,99%
|
ICP 2020 I K/S (CVR 41678720)
|
NORMAL
|
23.10.2020
|
20,00-24,99%
|
20,00-24,99%
|
Sunstone Life Science Ventures Fund IV K/S (CVR 38778536)
|
NORMAL
|
30.09.2020
|
10,00-14,99%
|
10,00-14,99%
|
SEED Capital Denmark III K/S (CVR 36988665)
|
NORMAL
|
01.04.2020
|
10,00-14,99%
|
10,00-14,99%
|
HyperBio Therapeutics ApS (CVR 41244909)
|
NORMAL
|
12.03.2020
|
100,00%
|
100,00%
|
ENV HoldCo A/S (CVR 39832054)
|
UNDERFRIVILLIGLIKVIDATION
|
11.09.2018
|
100,00%
|
100,00%
|
Novo Invest 1 A/S (CVR 36733020)
|
NORMAL
|
22.06.2015
|
100,00%
|
100,00%
|
XELLIA HOLDCO A/S (CVR 34880549)
|
NORMAL
|
15.07.2013
|
100,00%
|
100,00%
|
Saga IV EUR-A K/S (CVR 31585201)
|
NORMAL
|
01.07.2008
|
5,00-9,99%
|
5,00-9,99%
|
NOVO NORDISK A/S (CVR 24256790)
|
NORMAL
|
13.11.2000
|
25,00-33,32%
|
66,67-89,99%
|
NOVO VENTURES 1 P/S (CVR 24257185)
|
NORMAL
|
16.10.2000
|
100,00%
|
100,00%
|